Having trouble viewing this email? View in your browser.
ESCMID Logo

26 November 2019
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 

ECCMID 2020 Abstract submission – only 31 hours remaining!

Be sure to complete the submission of your scientific abstract for the world’s premier meeting in the field of infectious diseases and clinical microbiology.

The submission portal will close on Wednesday, 27 November 2019 at 23:59 CET.

› Read more

ESCMID Postgraduate Technical Workshop: Applications of MALDI-TOF Mass-Spectrometry in Clinical Microbiology

Don’t miss out on the upcoming course ‘Applications of MALDI-TOF Mass-Spectrometry in Clinical Microbiology’, coming up in Madrid from 16-18 March 2020.

Attendance grants are available for ESCMID members, apply online on the course website before 31 December 2019.

Find out about this and other upcoming ESCMID Postgraduate Courses and Workshops at the ESCMID 2020 Courses website.

› Read more

Join us at ECCMID 2020 to experience the Symposium
“Recent top papers in migrant health and neglected infections” co-organized by ESGCP (ESCMID Study group for Clinical Parasitology) and ESGITM (ESCMID Study Group for Infections in Travellers and Migrants)

Speakers: Richard O. Phillips, Marie L. Nřrredam

Migrant health concerns healthcare professionals across many specialties, including infectious disease specialists and clinical microbiologist. Neglected tropical diseases (NTD) may be missed due to a lack of awareness of relevant screening as well as directed diagnostics. This 1-hour symposium aims to give an up-to-date overview on the most interesting and impactful papers on migrant health and NTD in the last year.

Visit ECCMID Live to discover more about our scientific programme and register now to take advantage of early registration discounts!

› Read more
 

ESCMID Executive Committee Elections – Have your say!

You may now cast your vote in the 2019 ESCMID Executive Committee election and determine who will represent your interests and your area of practice at our society. 
You will find the biographies of the candidates, as well as the ballot, on the ESCMID website.

The online election for the ESCMID Executive Committee is open until Thursday, 12 December 2019 at 12:00 noon CET. Only currently paid-up members in good standing may vote, so make sure you renew your membership if needed.

› Read more
 

Pre-ECCMID workshop – Machine Learning for Clinical Microbiology

Don’t miss the cutting-edge pre-ECCMID workshop, ‘Machine Learning for Clinical Microbiology’. In an exciting mixture of interactive tutorials, lectures and workshops, this workshop ensures that you have the skills to collect, collate and deal with the huge amounts of data available to today’s clinical microbiologist.

Find out more on the ECCMID website

› Read more
 

CMI highlight: Emerging non-PCV13 serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain

A. González et al, observed an early reduction of adult invasive pneumococcal disease (IPD) after the 13-valent pneumococcal conjugate vaccine (PCV13) introduction for children in Spain. The authors analysed the epidemiology of adult IPD in the late-PCV13 period. Streptococcus pneumoniae is a major human pathogen that causes pneumonia, meningitis and other severe IPDs as well as non-invasive infections. Nowadays, several years after the introduction of PCV13, a rebound in IPD has been noticed in some European countries associated with a rise of non-PCV13 serotypes.

This was a prospective multicentre study of adult IPD involving six hospitals. Strains were serotyped, genotyped and studied for antimicrobial susceptibility. The late-PCV13 period was compared with pre and early-PCV13 periods.

The authors found that the initial decrease of adult IPD observed after PCV13 introduction for children has been balanced by the rise of non-PCV13 serotypes. The spread of antibiotic-resistant lineages related to non-PCV13 serotypes could be a threat for the treatment of serious pneumococcal diseases.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.